Zaid N, Bastiaannet R, Hobbs R, Sgouros G
J Nucl Med. 2025; 66(1):84-90.
PMID: 39753362
PMC: 11705791.
DOI: 10.2967/jnumed.124.268457.
Lopez-Cavestany M, Wright O, Reckhorn N, Carter A, Jayawardana K, Nguyen T
ACS Nano. 2024; 18(34):23637-23654.
PMID: 39150223
PMC: 11363216.
DOI: 10.1021/acsnano.4c08132.
Peters J, van Dijck J, Elias S, Otten J, Broeders M
J Med Screen. 2024; 31(3):166-175.
PMID: 38295359
PMC: 11330081.
DOI: 10.1177/09691413231222765.
Nayila I, Sharif S, Lodhi M, Rehman M, Aman F
RSC Adv. 2023; 13(46):32335-32362.
PMID: 37928847
PMC: 10621725.
DOI: 10.1039/d3ra06335f.
Ocana-Tienda B, Perez-Beteta J, Jimenez-Sanchez J, Molina-Garcia D, Ortiz de Mendivil A, Asenjo B
NPJ Syst Biol Appl. 2023; 9(1):35.
PMID: 37479705
PMC: 10361973.
DOI: 10.1038/s41540-023-00298-1.
SMITH: spatially constrained stochastic model for simulation of intra-tumour heterogeneity.
Streck A, Kaufmann T, Schwarz R
Bioinformatics. 2023; 39(3).
PMID: 36825830
PMC: 10010604.
DOI: 10.1093/bioinformatics/btad102.
Inferring parameters of cancer evolution in chronic lymphocytic leukemia.
Lee N, Bozic I
PLoS Comput Biol. 2022; 18(11):e1010677.
PMID: 36331987
PMC: 9668150.
DOI: 10.1371/journal.pcbi.1010677.
A global method for fast simulations of molecular dynamics in multiscale agent-based models of biological tissues.
Bergman D, Sweis R, Pearson A, Nazari F, Jackson T
iScience. 2022; 25(6):104387.
PMID: 35637730
PMC: 9142654.
DOI: 10.1016/j.isci.2022.104387.
Monocytes engineered with iSNAP inhibit human B-lymphoma progression.
Wu H, Amirfakhri S, Lin H, Hollandsworth H, Filemoni F, Liu Y
Bioeng Transl Med. 2022; 7(2):e10285.
PMID: 35600645
PMC: 9115687.
DOI: 10.1002/btm2.10285.
Assessing lead time bias due to mammography screening on estimates of loss in life expectancy.
Syriopoulou E, Gasparini A, Humphreys K, Andersson T
Breast Cancer Res. 2022; 24(1):15.
PMID: 35197123
PMC: 8867879.
DOI: 10.1186/s13058-022-01505-3.
Delineating the evolutionary dynamics of cancer from theory to reality.
Bozic I, Wu C
Nat Cancer. 2022; 1(6):580-588.
PMID: 35121980
DOI: 10.1038/s43018-020-0079-6.
Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort.
Strandberg R, Czene K, Eriksson M, Hall P, Humphreys K
Cancer Epidemiol Biomarkers Prev. 2022; 31(3):569-577.
PMID: 35027432
PMC: 9306270.
DOI: 10.1158/1055-9965.EPI-21-1011.
A validated mathematical model of FGFR3-mediated tumor growth reveals pathways to harness the benefits of combination targeted therapy and immunotherapy in bladder cancer.
Okuneye K, Bergman D, Bloodworth J, Pearson A, Sweis R, Jackson T
Comput Syst Oncol. 2022; 1(2).
PMID: 34984415
PMC: 8722426.
DOI: 10.1002/cso2.1019.
Preclinical meritorious anticancer effects of Metformin against breast cancer: An trial.
Rizvi F, Shaukat L, Azhar A, Jafri A, Aslam U, Imran-Ul-Haq H
J Taibah Univ Med Sci. 2021; 16(4):504-512.
PMID: 34408607
PMC: 8348326.
DOI: 10.1016/j.jtumed.2021.02.006.
Tumour volume distribution can yield information on tumour growth and tumour control.
Schneider U, Besserer J
Z Med Phys. 2021; 32(2):143-148.
PMID: 34119384
PMC: 9948830.
DOI: 10.1016/j.zemedi.2021.04.002.
Lung Cancer Radiotherapy: Simulation and Analysis Based on a Multicomponent Mathematical Model.
Hong W, Wang S, Zhang G
Comput Math Methods Med. 2021; 2021:6640051.
PMID: 34012477
PMC: 8105103.
DOI: 10.1155/2021/6640051.
Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE.
Pettersson O, Fross-Baron K, Crona J, Sundin A
Endocr Connect. 2021; 10(4):422-431.
PMID: 33875614
PMC: 8111309.
DOI: 10.1530/EC-21-0027.
Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting.
Oberg A, Heinzen E, Hou X, Al Hilli M, Hurley R, Wahner Hendrickson A
Sci Rep. 2021; 11(1):8076.
PMID: 33850213
PMC: 8044116.
DOI: 10.1038/s41598-021-87470-x.
Measuring differences between phenomenological growth models applied to epidemiology.
Burger R, Chowell G, Lara-Diaz L
Math Biosci. 2021; 334:108558.
PMID: 33571534
PMC: 8054577.
DOI: 10.1016/j.mbs.2021.108558.
Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM study.
Graillon T, Ferrer L, Siffre J, Sanson M, Peyre M, Peyriere H
Neuro Oncol. 2021; 23(7):1139-1147.
PMID: 33556177
PMC: 8661407.
DOI: 10.1093/neuonc/noab019.